The Exchange has sought clarification from Jubilant Life Sciences Limited with respect to recent news item captioned "Jubilant's Rs.250cr project gets nod". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.